Translational Program Grant

Partnership with Cancer Institute NSW to fund translational research

Cancer Council NSW and Cancer Institute NSW collaborate to fund world-class translational research. 

The research will provide the evidence to drive rapid improvements in cancer prevention, treatment and subsequently survival and quality of life for cancer patients in NSW. 

Translational Program Grants provide five year funding to support multi-disciplinary approaches to cancer research that will rapidly translate research discoveries into clinical programs and policy.  This may include programs which focus on the relevance of a biological discovery in human cancer risk, early detection, screening, prevention, diagnosis, prognosis and/or treatment or the translation of known effective treatments into clinical practice across the system by developing a program of practice-based research and dissemination or implementation research. 

Funding is to a maximum of $750,000 per annum x 5 years per application.

Applications are open to members of the Translational Cancer Research Centres.

One Translational Program Grant each will be awarded by Cancer Council NSW and Cancer Institute NSW in 2021 with total funding up to $3.75 million for each award. 

From this year, as well as completing the scientific application, applicants will need to complete a separate application form for consumer review. Please refer to the below guidelines for more information.


Application Forms

How to Apply

Application submission, including Consumer Review Form, is via the Cancer Institute NSW Grants Management System

  • Expression of Interest – Open 26 February 2020 and close 1pm 25 March 2020
  • Full Applications will be by invitation – Open 13 May 2020 and close 1pm 17 August 2020


Please direct enquiries about the grant scheme to CINSW – Or

For queries specific to online applications via the Cancer Institute’s Grants Management System, please contact

With just $20 a month, you can help fund life-saving research, prevent cancer for future generations, and get cancer patients the support they need, when they need it most.